Field leaders will negotiate the latest advances in:
- Congenital Heart Disease drugs/devices
The focus of the 2020 Meeting will be on Heart Failure and End-Stage CHD. As with previous years, there will be a plenary session in Pulmonary Arterial Hypertension in association with Congenital Heart Disease, plus two extended case discussion sessions.
If you would like to put forward a case for discussion at the meeting, please contact email@example.com details on how to submit your case for inclusion.